MA45982A - Compositions de neurostéroïdes et leurs procédés d'utilisation - Google Patents
Compositions de neurostéroïdes et leurs procédés d'utilisationInfo
- Publication number
- MA45982A MA45982A MA045982A MA45982A MA45982A MA 45982 A MA45982 A MA 45982A MA 045982 A MA045982 A MA 045982A MA 45982 A MA45982 A MA 45982A MA 45982 A MA45982 A MA 45982A
- Authority
- MA
- Morocco
- Prior art keywords
- neurosteroid
- compositions
- methods
- neurosteroid compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B7/00—Separation of mixtures of fats or fatty oils into their constituents, e.g. saturated oils from unsaturated oils
- C11B7/0075—Separation of mixtures of fats or fatty oils into their constituents, e.g. saturated oils from unsaturated oils by differences of melting or solidifying points
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C1/00—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids
- C11C1/02—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids from fats or fatty oils
- C11C1/04—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids from fats or fatty oils by hydrolysis
- C11C1/045—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids from fats or fatty oils by hydrolysis using enzymes or microorganisms, living or dead
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C1/00—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids
- C11C1/08—Refining
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/01—Carboxylic ester hydrolases (3.1.1)
- C12Y301/01004—Phospholipase A2 (3.1.1.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Biotechnology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662375676P | 2016-08-16 | 2016-08-16 | |
US201662402439P | 2016-09-30 | 2016-09-30 | |
US15/354,114 US20180050005A1 (en) | 2016-08-16 | 2016-11-17 | Concentrated Solution of 17-Hydroxydocosahexaenoic Acid |
Publications (1)
Publication Number | Publication Date |
---|---|
MA45982A true MA45982A (fr) | 2019-06-26 |
Family
ID=61190207
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA045982A MA45982A (fr) | 2016-08-16 | 2017-08-15 | Compositions de neurostéroïdes et leurs procédés d'utilisation |
Country Status (5)
Country | Link |
---|---|
US (1) | US20180050005A1 (fr) |
EP (1) | EP3500266A1 (fr) |
CN (1) | CN110121346A (fr) |
MA (1) | MA45982A (fr) |
WO (1) | WO2018035095A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2019104004A (ru) | 2012-01-23 | 2019-03-07 | Сейдж Терапьютикс, Инк. | Лекарственные формы нейроактивных стероидов и способы лечения нарушений цнс |
DK2925327T3 (da) | 2012-11-30 | 2024-03-25 | Univ California | Allopregnanolon til behandling, reduktion eller lindring af symptomer på fødselsdepression |
MA43815A (fr) | 2016-03-08 | 2021-04-07 | Sage Therapeutics Inc | Stéroïdes neuroactifs, compositions, et leurs utilisations |
CN113925832B (zh) * | 2020-07-13 | 2023-06-16 | 苏州特瑞药业股份有限公司 | 一种别孕烯醇酮的脂质体及其制备方法 |
CN114432245B (zh) * | 2020-11-06 | 2023-10-03 | 上海参素药物技术有限公司 | 一种人参皂苷紫杉醇脂质体、其制备方法和应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4125605A (en) | 1977-10-19 | 1978-11-14 | The United States Government | Method of employing oral TRH |
US4902788A (en) | 1988-09-29 | 1990-02-20 | Uop | Crosslinked cyclodextrins supported on porous refractory inorganic oxides |
EP0644771B2 (fr) | 1992-06-11 | 2006-12-06 | Alkermes Controlled Therapeutics, Inc. | Systeme d'apport de medicament sous forme d'erythropoietine |
US5354934A (en) | 1993-02-04 | 1994-10-11 | Amgen Inc. | Pulmonary administration of erythropoietin |
EP1868593A2 (fr) * | 2005-04-07 | 2007-12-26 | Hythiam, Inc. | Procedes ameliores et compositions permettant de prevenir l'anxiete, l'abus d'une substance et la dependance |
KR20140098741A (ko) * | 2011-10-07 | 2014-08-08 | 플로리다 스테이트 유니버시티 리서치 파운데이션, 인크 | 뇌진탕과 연관된 더 나은 결과에 대한 프로게스테론의 예방적 및 후-급성 용도 |
RU2019104004A (ru) * | 2012-01-23 | 2019-03-07 | Сейдж Терапьютикс, Инк. | Лекарственные формы нейроактивных стероидов и способы лечения нарушений цнс |
CN103417479A (zh) * | 2012-05-16 | 2013-12-04 | 吉林大学 | 一种人参皂苷Rg3脂质体及其制备方法 |
CN103271891B (zh) * | 2013-04-28 | 2016-01-06 | 福建南方制药股份有限公司 | 人参皂苷纳米胶束及其制备方法、应用和药物组合物 |
CN104288188B (zh) * | 2014-09-19 | 2017-06-09 | 罗颂平 | 续断总皂苷在制备安胎药物中的应用 |
CN105708847B (zh) * | 2016-02-02 | 2019-01-04 | 成都大学 | 人参皂苷多组分共载靶向纳米体系的制备方法及其应用 |
CN105534911A (zh) * | 2016-02-04 | 2016-05-04 | 大连民族大学 | 20(R)-人参皂苷Rg3/阳离子类脂/胆固醇/叶酸脂质体药物及其制备方法和应用 |
-
2016
- 2016-11-17 US US15/354,114 patent/US20180050005A1/en not_active Abandoned
-
2017
- 2017-08-15 EP EP17758342.4A patent/EP3500266A1/fr not_active Withdrawn
- 2017-08-15 MA MA045982A patent/MA45982A/fr unknown
- 2017-08-15 CN CN201780063850.8A patent/CN110121346A/zh active Pending
- 2017-08-15 WO PCT/US2017/046894 patent/WO2018035095A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
EP3500266A1 (fr) | 2019-06-26 |
CN110121346A (zh) | 2019-08-13 |
US20180050005A1 (en) | 2018-02-22 |
WO2018035095A1 (fr) | 2018-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA46566A (fr) | Oxystérols et leurs procédés d'utilisation | |
MA44524A (fr) | Néoantigènes et leurs procédés d'utilisation | |
MA55097A (fr) | Oxystérols et leurs procédés d'utilisation | |
MA41999A (fr) | Compositions d'acide obéticholique et procédés d'utilisation | |
MA44740A (fr) | Variantes de capsides de virus adéno-associé et leurs procédés d'utilisation | |
MA53355A (fr) | Anticorps anti-ctla-4 et leurs procédés d'utilisation | |
MA42409A (fr) | Oxystérols et leurs procédés d'utilisation | |
MA46565A (fr) | Oxystérols et leurs procédés d'utilisation | |
MA46427A (fr) | Compositions d'oligonucléotides et procédés associés | |
MA54851A (fr) | Oxystérols et leurs procédés d'utilisation | |
MA47499A (fr) | Anticorps anti-tau et leurs procédés d'utilisation | |
MA42043A (fr) | Anticorps anti-ox40 et procédés d'utilisation de ceux-ci | |
MA41558A (fr) | Compositions d'allergènes mélangés et leurs procédés d'utilisation | |
MA54252A (fr) | Composés de benzoxazépine oxazolidinone et leurs procédés d'utilisation | |
MA44490A (fr) | Adhésifs biocompatibles et leurs procédés d'utilisation | |
MA47849A (fr) | Anticorps anti-gitr et leurs procédés d'utilisation | |
MA43389A (fr) | Anticorps anti-ox40 et leurs procédés d'utilisation | |
MA40069A (fr) | Molécules de liaison trispécifiques et leurs procédés d'utilisation | |
MA51552A (fr) | Anticorps anti-ox40 et procédés d'utilisation | |
MA45270A (fr) | Compositions d'oligonucléotides et procédés associés | |
MA44081A (fr) | Anticorps anti-c5 et leurs procédés d'utilisation | |
MA45982A (fr) | Compositions de neurostéroïdes et leurs procédés d'utilisation | |
MA46586A (fr) | Compositions de terlipressine et leurs procédés d'utilisation | |
MA48797A (fr) | Variants de l'endonucléase cblb , compositions et procédés d'utilisation | |
MA39915B1 (fr) | Composés de pladiénolide pyridine et leurs procédés d'utilisation |